Skip to main content

Blog

Santhera announces exclusive North America license agreement with Catalyst Pharmaceuticals for vamorolone

...

Thanks to you PPMD continues forward in all areas of support

...

WATCH: ENVISION Study Update With Sarepta Therapeutics (Webinar Recording)

...

PPMD Announces Pediatric Certified Duchenne Care Center at Norton Children’s Hospital

...

PPMD publishes results of study to understand Duchenne patients’ and caregivers’ perspectives on corticosteroids

...

PPMD Announces Pediatric Certified Duchenne Care Center at Boston Children’s Hospital

...

PPMD, CureDuchenne, Muscular Dystrophy Association Announce Collaborative Project to Focus on Re-Dosing Gene Therapy in Duchenne Muscular Dystrophy

...

Over 1,000 Free Carrier Tests Performed through PPMD’s Decode Duchenne Program!

...

Sarepta Announces Update on ENVISION Study Enrollment in U.S.

...

FibroGen Announces Topline Data from Phase 3 LELANTOS-1 Study

...